SynMetabio Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 100

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $14.5M

  • Investors
  • 10

SynMetabio General Information

Description

Developer of next-generation sustainable biomaterials designed for synthetic biology. The company offers the next generation of biological basic materials through protein design at the genetic level and drought regulation at the species level, thereby enabling clothing companies to reduce environmental pollution during production.

Contact Information

Website
www.synmetabio.com
Formerly Known As
Shanghai Yiru Biotechnology
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 5th Floor, Jiehui Science and Technology Innovation Center, Number 430 Miaoqiao Road
  • Kangqiao Town, Pudong New Area
  • Shanghai, 201315
  • China
+86 139
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Other Materials
Vertical(s)
CleanTech, LOHAS & Wellness
Corporate Office
  • 5th Floor, Jiehui Science and Technology Innovation Center, Number 430 Miaoqiao Road
  • Kangqiao Town, Pudong New Area
  • Shanghai, 201315
  • China
+86 139

SynMetabio Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SynMetabio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC (Series A) 10-Apr-2026 $14.5M Completed Generating Revenue
4. Early Stage VC (Series A) 20-Jun-2025 Completed Generating Revenue
3. Early Stage VC 31-Dec-2023 Completed Generating Revenue
2. Early Stage VC 26-Apr-2023 Completed Generating Revenue
1. Seed Round 26-Apr-2022 Completed Startup
To view SynMetabio’s complete valuation and funding history, request access »

SynMetabio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SynMetabio Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Hangzhou Chaosheng Investment Management Growth/Expansion Minority
Heda Ventures Venture Capital Minority
Ordos Group Corporation Minority
Star Capital Investment Management Growth/Expansion Minority
Danen Capital Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

Ready to get started?

Request a free trial

SynMetabio FAQs

  • When was SynMetabio founded?

    SynMetabio was founded in 2021.

  • Where is SynMetabio headquartered?

    SynMetabio is headquartered in Shanghai, China.

  • What is the size of SynMetabio?

    SynMetabio has 100 total employees.

  • What industry is SynMetabio in?

    SynMetabio’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is SynMetabio a private or public company?

    SynMetabio is a Private company.

  • What is SynMetabio’s current revenue?

    The current revenue for SynMetabio is .

  • How much funding has SynMetabio raised over time?

    SynMetabio has raised $14.5M.

  • Who are SynMetabio’s investors?

    Hangzhou Chaosheng Investment Management, Heda Ventures, Ordos Group, Star Capital Investment Management, and Danen Capital are 5 of 10 investors who have invested in SynMetabio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process